Medlior is a well-known and trusted industry leader.
Our team is dedicated to delivering high-quality research that provides a solid basis for informed decision-making.
Medlior’s Expert Angle offers the inside track on new studies, industry hot topics, and what you need to know in the fast-paced world of clinical research, all from the point of view of the Medlior team of experts. From the latest topics and trends to the foundations of health and medical research, Medlior explores topics relevant to clients and the world.
What is Synthetic Data?
Synthetic data is the generation of realistic datasets that capture important relationships and information from real-world data. These datasets are created through random sampling models, such as Bayesian or neural networks, with the help of domain experts to validate ...
People who use drugs, particularly opioids, are a group that has been disproportionately impacted by the COVID-19 pandemic. Safe consumption sites and homeless shelters are supports often relied upon by people who use drugs. During the pandemic, these supports have been, in some cases, ...
Explore a list of all of Medlior's recent publications including recent Medlior evidence generation publications and recent Medlior RWE publications.
Recent Medlior RWE publications
Scory T, Chen G, Farris M, Shih YH, Pinto L, Cowling T. Lipid-lowering therapy patterns and low-density ...
Across the globe, the COVID-19 pandemic has negatively impacted healthcare delivery including:
delays in elective or non-urgent surgeries and procedures,
disruptions to cancer screening, and
cessation of routine laboratory tests.
In Canada, the Canadian Institute for Health ...
The Canadian Survey on Disability (CSD) is a repeated cross-sectional survey of Canadians 15 years of age and older living with disability.1 Conducted by Statistics Canada, CSD participants are recruited from individuals who reported having a long-term health related condition or difficulty on ...
Medlior was pleased to work with the Canadian Agency for Drugs and Technologies in Health (CADTH) to prepare a report on virus-neutralizing monoclonal antibodies for the treatment of SARS-CoV-2 infection, as part of CADTH’s Coronavirus Disease (COVID-19) evidence bundle.
The Medlior team ...
In January of 2020, we started the year with a passion for innovation and collaboration to produce impactful health outcomes research projects. We certainly could not have predicted the year that would follow, and while it was unprecedented, it also emphasized the vital role of health research ...
There’s not much that can be said about 2020 that hasn’t already been said. Unpredictable, unprecedented, unparalleled, 2020 will be remembered for a lot of things.
But as we look towards 2021, we’re seeing hope like we haven’t seen in many months. With vaccines getting approved from ...
The top 100 Canadian businesses are presented by Scotiabank Women Initiative, the National Post, and Visa Canada
Calgary, AB (December 1, 2020) - Calgary business owner and founder of Medlior Health Research Outcomes Ltd, Tara Cowling, has been named as one of the Top 100 female entrepreneurs ...
Medlior presents the recent publication, “Indirect analysis of first-line therapy for advanced non-small cell lung cancer with activating mutations in the Japanese population,” on first-line treatments of epidermal growth factor receptor mutation positive (EGFR+) non small cell lung cancer ...
Updated overall survival on the first-line treatments for advanced epidermal growth factor receptor mutation positive non-small cell lung cancer
Lung cancer is the leading cause of death in Canada, with approximately 29,300 Canadians developing lung cancer in 2019.1 There are two forms of ...
This site uses functional cookies and external scripts to improve your experience.
Stay informed by signing up here to receive our newsletter.
Keep informed and stay up-to-date on the latest industry-related information with a complimentary subscription to our newsletter.
Privacy settings
Privacy Settings
This site uses functional cookies and external scripts to improve your experience. Which cookies and scripts are used and how they impact your visit is specified on the left. You may change your settings at any time. Your choices will not impact your visit.
NOTE: These settings will only apply to the browser and device you are currently using.
Google Tag Manager
Allow Google (and possibly other tracking services such as Facebook) to follow my actions on the website.